V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270016394 | 270009134 | 1.68 | 70.9 | Palliative (P) | 2013-03-19 | 2013-05-12 | Rituximab | N | N | 270015090 | RITUXIMAB |
| 270016395 | 270019160 | 1.63 | null | Curative (C) | 2015-04-14 | 2015-04-19 | BEAM | N | N | 270015095 | BEAM |
| 270016396 | 270019160 | null | 69 | Adjuvant (A) | 2018-04-18 | 2018-04-25 | BEAM | 02 | N | 270015095 | BEAM |
| 270016397 | 270019160 | 1.76 | 51.4 | Curative (C) | 2015-02-27 | 2015-02-27 | ESHAP | 2 | N | 270015095 | ESHAP |
| 270016398 | 270009135 | 1.8 | 73.05 | Palliative (P) | 2016-05-02 | 2016-06-11 | Cetuximab + FOLFIRI cycle 2 onwards | N | Y | 270015100 | CETUXIMAB + IRINOTECAN + MDG |
| 270016399 | 270014276 | 1.61 | 66.8 | Palliative (P) | 2016-02-16 | 2016-02-16 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | 270015105 | CETUXIMAB + IRINOTECAN + MDG |
| 270016400 | 270014277 | 1.61 | 59 | Curative (C) | null | 2018-05-06 | Cisplatin + Radiotherapy | N | Y | 270015112 | CISPLATIN + RT |
| 270016401 | 270009142 | 1.78 | 88.5 | Curative (C) | 2018-09-06 | 2018-09-07 | OEPA | N | N | 270015115 | OEPA |
| 270016402 | 270009143 | 1.74 | 92 | Curative (C) | 2017-04-19 | 2017-04-21 | OEPA | 02 | N | 270015115 | OEPA |
| 270016403 | 270020070 | 1.72 | 75 | Curative (C) | 2017-06-30 | 2017-11-07 | BEAM | 02 | N | 270015118 | BEAM |
| 270016404 | 270009145 | null | null | Curative (C) | 2016-08-30 | 2016-09-20 | ESHAP | N | N | 270015123 | ESHAP |
| 270016405 | 270009147 | 1.61 | null | Curative (C) | 2015-09-02 | 2015-11-10 | ESHAP | N | N | 270015126 | ESHAP |
| 270016406 | 270018316 | 1.74 | 61 | Palliative (P) | 2016-12-11 | 2018-01-29 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 270015130 | CETUXIMAB + IRINOTECAN + MDG |
| 270016407 | 270009152 | 1.69 | 84 | Curative (C) | 2017-12-29 | 2017-12-30 | LEAM | N | N | 270015132 | LEAM |
| 270016408 | 270009155 | null | 73.6 | Curative (C) | 2018-02-27 | 2018-03-01 | ESHAP | 02 | N | 270015133 | ESHAP |
| 270016409 | 270009159 | 1.73 | 85 | Curative (C) | 2018-02-02 | 2018-02-03 | BEAM | null | null | 270015135 | BEAM |
| 270016410 | 270016838 | 1.62 | 72.5 | Curative (C) | 2017-11-08 | 2017-11-08 | ESHAP | 02 | N | 270015139 | ESHAP |
| 270016411 | 270009160 | null | 85.8 | Curative (C) | null | 2018-12-09 | BEAM | N | null | 270015146 | BEAM |
| 270016412 | 270009160 | 1.72 | 92.9 | Curative (C) | 2017-06-23 | 2017-07-19 | BEAM | N | N | 270015146 | BEAM |
| 270016413 | 270009161 | 1.81 | 97 | Curative (C) | 2018-05-02 | 2018-05-02 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270015185 | CETUXIMAB + IRINOTECAN + MDG |
| 270016414 | 270014287 | 0 | 23.55 | Curative (C) | 2016-01-06 | 2016-01-12 | Cisplatin + Radiotherapy | 02 | N | 270015193 | CISPLATIN + RT |
| 270016415 | 270009166 | 0 | 76.2 | Disease modification (D) | 2014-11-27 | 2014-12-07 | LEAM | null | null | 270015197 | LEAM |
| 270016416 | 270009167 | 1.54 | 59 | Palliative (P) | 2016-02-10 | 2016-04-06 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270015198 | CETUXIMAB + IRINOTECAN + MDG |
| 270016417 | 270009168 | 1.82 | 84.4 | Curative (C) | 2016-03-28 | 2016-03-30 | BEAM | 02 | N | 270015199 | BEAM |
| 270016418 | 270009169 | 1.88 | 85.8 | Adjuvant (A) | 2014-01-19 | 2014-01-19 | CISPLATIN + RT | N | N | 270015201 | CISPLATIN + RT |
| 270016419 | 270014291 | 1.75 | 120 | Palliative (P) | 2017-03-29 | 2017-04-22 | CETUXIMAB + IRINOTECAN + MDG | 2 | null | 270015205 | CETUXIMAB + IRINOTECAN + MDG |
| 270016420 | 270009172 | null | 73.6 | Curative (C) | 2016-02-07 | 2016-03-05 | CISPLATIN + RT | N | null | 270015207 | CISPLATIN + RT |
| 270016421 | 270014292 | 1.56 | 70.6 | Disease modification (D) | 2016-02-08 | 2016-07-12 | Rituximab (Maintenance) | N | N | 270015209 | RITUXIMAB |
| 270016422 | 270009175 | 1.68 | 84.6 | Disease modification (D) | null | 2017-05-20 | BEAM | 02 | Y | 270015214 | BEAM |
| 270016423 | 270009177 | 1.88 | 67.199 | Palliative (P) | 2013-07-15 | 2013-09-06 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270015218 | CETUXIMAB + IRINOTECAN + MDG |
| 270016424 | 270009180 | 1.61 | 67.5 | Curative (C) | 2018-02-16 | 2018-03-03 | Cisplatin 100 + RT(H&N) 1 day | null | null | 270015219 | CISPLATIN + RT |
| 270016425 | 270009181 | 1.73 | 85.5 | Palliative (P) | null | 2016-10-21 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 270015224 | CETUXIMAB + IRINOTECAN + MDG |
| 270016426 | 270018323 | 1.82 | 69.7 | Neo-adjuvant (N) | 2017-01-31 | 2017-02-04 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270015225 | CETUXIMAB + IRINOTECAN + MDG |
| 270016427 | 270009183 | 1.83 | null | Curative (C) | 2014-10-18 | 2017-08-25 | ESHAP | N | N | 270015226 | ESHAP |
| 270016428 | 270009185 | 1.58 | 62.4 | Curative (C) | 2016-06-15 | 2016-07-06 | BEAM | 02 | N | 270015227 | BEAM |
| 270016429 | 270009185 | null | 67.7 | Curative (C) | 2013-04-10 | 2013-05-18 | CISPLATIN + RT | N | N | 270015227 | CISPLATIN + RT |
| 270016430 | 270009187 | 1.65 | 57.6 | Curative (C) | 2016-10-04 | 2016-10-14 | Rituximab | N | N | 270015236 | RITUXIMAB |
| 270016431 | 270009190 | 1.77 | 98.3 | Curative (C) | 2017-09-05 | 2017-09-28 | Cisplatin 100 + RT(H&N) 1 day | 2 | null | 270015239 | CISPLATIN + RT |
| 270016432 | 270009192 | 1.57 | null | null | 2016-01-13 | 2016-02-11 | ESHAP | null | null | 270015246 | ESHAP |
| 270016433 | 270009194 | 1.8 | 71.7 | Disease modification (D) | 2017-05-07 | 2017-05-07 | ESHAP | N | N | 270015247 | ESHAP |
| 270016434 | 270009195 | 1.73 | 93.6 | Curative (C) | 2014-08-10 | 2014-09-01 | LEAM | null | null | 270015247 | LEAM |
| 270016435 | 270009195 | 1.82 | 53.3 | Curative (C) | 2017-12-02 | 2017-12-03 | ESHAP | N | N | 270015247 | ESHAP |
| 270016436 | 270014302 | 1.8 | 66 | Curative (C) | 2015-07-22 | 2015-07-22 | ESHAP | N | null | 270015252 | ESHAP |
| 270016437 | 270009200 | 1.84 | 52 | Curative (C) | 2017-02-16 | 2017-02-17 | OEPA | 2 | N | 270015254 | OEPA |
| 270016438 | 270009203 | 1.59 | null | null | 2017-02-27 | 2017-02-28 | CISPLATIN + RT | N | N | 270015268 | CISPLATIN + RT |
| 270016439 | 270009205 | null | 0 | Curative (C) | 2016-12-18 | 2016-12-18 | Cisplatin 100 + RT(H&N) 1 day | 02 | Y | 270015269 | CISPLATIN + RT |
| 270016440 | 270009209 | 1.71 | 69.7 | Palliative (P) | 2017-07-15 | 2017-08-18 | Cetuximab + FOLFIRI cycle1 | N | null | 270015275 | CETUXIMAB + IRINOTECAN + MDG |
| 270016441 | 270016853 | 0 | 98 | Curative (C) | 2016-08-02 | 2016-08-09 | HD EuroNet-PHL-C1 OEPA | 2 | N | 270015276 | OEPA |
| 270016442 | 270009213 | 1.69 | 56 | Curative (C) | 2014-10-18 | 2014-10-20 | ESHAP | N | N | 270015286 | ESHAP |
| 270016443 | 270019172 | null | 113 | Palliative (P) | 2015-07-26 | 2015-09-20 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270015289 | CETUXIMAB + IRINOTECAN + MDG |